Loading company…
Mirina develops therapeutics targeting cellular processes involving microRNAs.
Mirina Corp. develops therapeutics that affect cellular processes involving microRNAs. Its technology is intended for diseases including cancers, infectious diseases and metabolic disorders.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in